Department of Medical and Surgical Sciences, Division of Internal Medicine, Maternal-Infantile and Adult, University of Modena and Reggio Emilia, 41126 Modena, Italy.
Postgraduate School of Allergy and Clinical Immunology, University of Modena and Reggio Emilia, 41126 Modena, Italy.
Viruses. 2021 Sep 4;13(9):1767. doi: 10.3390/v13091767.
The hepatitis B virus is responsible for most of the chronic liver disease and liver cancer worldwide. As actual therapeutic strategies have had little success in eradicating the virus from hepatocytes, and as lifelong treatment is often required, new drugs targeting the various phases of the hepatitis B virus (HBV) lifecycle are currently under investigation. In this review, we provide an overview of potential future treatments for HBV.
乙型肝炎病毒是全球大多数慢性肝病和肝癌的罪魁祸首。由于实际的治疗策略在从肝细胞中根除病毒方面收效甚微，而且通常需要终身治疗，因此目前正在研究针对乙型肝炎病毒 (HBV) 生命周期各个阶段的新药。在这篇综述中，我们概述了 HBV 的潜在未来治疗方法。
